Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine
- 30 October 2003
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 225 (2) , 65-74
- https://doi.org/10.1016/j.cellimm.2003.09.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunityCancer Immunology, Immunotherapy, 2001
- Active immunization against cancer with dendritic cells: the near future.International Journal of Cancer, 2001
- Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingNature Medicine, 2001
- Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cellsProceedings of the National Academy of Sciences, 2000
- Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cellsProceedings of the National Academy of Sciences, 1998
- Dendritic cells and the control of immunityNature, 1998
- Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cellsNature Medicine, 1997
- Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.The Journal of Experimental Medicine, 1996
- Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.The Journal of Experimental Medicine, 1996
- Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunityNature Medicine, 1995